IDH1 Inhibitor Drugs: Pioneering Targeted Cancer Therapies

أضاف وظيفة جديدة أخرى

2026-07-26 14:44:29 -

The discovery of mutations in the isocitrate dehydrogenase 1 (IDH1) gene in certain cancers, including acute myeloid leukemia and gliomas, has opened a new front in targeted oncology. IDH1 inhibitors are designed to specifically block the activity of this mutated enzyme, disrupting the production of the oncometabolite that drives tumor growth. According to WiseGuy Reports, the Isocitrate...

0 التعليقات 0 المشاركات 78 مشاهدة 0 معاينة